Jane Street’s Entasis Therapeutics Holdings Inc. ETTX Stock Holding History

Jane Street’s Portfolio ETTX Stock Details ETTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-30,262	Closed	-$67K	–	10970
2022 Q2	$67K	Buy	+30,262	New	+$60.4K	﹤0.01%	8827
2021 Q4	–	Sell	-32,177	Closed	-$107K	–	11115
2021 Q3	$107K	Buy	+32,177	New	+$87.3K	﹤0.01%	9264
2020 Q4	–	Sell	-20,820	Closed	-$42K	–	8385
2020 Q3	$42K	Buy	+20,820	New	+$59.4K	﹤0.01%	6948

Jane Street's ETTX Position: Q3 2022 in Review

Jane Street sold out of Entasis Therapeutics Holdings Inc. (ETTX) in Q3 2022, closing a stake of 30,262 shares — an estimated $67K sold.

Jane Street first reported a position in ETTX in Q3 2020 and held it in 3 quarters. The position peaked at $107K in Q3 2021. 0 funds tracked by Wall St. Rank hold ETTX as of Q3 2022.

Jane Street reported no remaining Entasis Therapeutics Holdings Inc. position as of Q3 2022 after selling out during the quarter.
Jane Street sold 30,262 Entasis Therapeutics Holdings Inc. shares in Q3 2022, an estimated $67K.
Jane Street first reported a position in Entasis Therapeutics Holdings Inc. in Q3 2020 and held it in 3 quarters.
Jane Street's Entasis Therapeutics Holdings Inc. position peaked at $107K in Q3 2021.
0 funds tracked by Wall St. Rank held Entasis Therapeutics Holdings Inc. as of Q3 2022.

Based on Jane Street's 13F filing for Q3 2022, filed 15 Nov 2022.